DURHAM, N.C.--(BUSINESS WIRE)--Sept. 11, 2006--Expression Analysis, Inc., a full-service microarray testing, analysis and data management organization, has announced its participation as an official data analysis site in the first phase of the Federal Drug Administration's MicroArray Quality Control (MAQC) Project. The completion of this phase of the project is described in several publications in September's issue of Nature Biotechnology. Expression Analysis' role was led by two of its senior scientists, Laura Reid, Ph.D, Director of Research & Development, and Wendell Jones, Ph.D., Director of Statistics and Bioinformatics.
